La cadena de opciones muestra datos clave de las opciones de acciones de Bio-Path Holdings a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Bio-Path Holdings..

Bio-Path Holdings (OTC:BPTH) Bolsa, Cadena de Opciones

Bio-Path Holdings

BIO-PATH HOLDINGS INC by Bio-Path Holdings, Inc.

Bio-Path Holdings Inc

Bio-Path Holdings (BPTH) Previsión

Noticias

Beneficios

Calificaciones de analistas

Operaciones de insiders

Interés en corto

Informe de acciones

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of a Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.

Comments

Bio-Path Holdings Cadena de Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL